ADR related questions received by a telephone medicines information service and ADRs received by a spontaneous ADR reporting system: A comparison regarding patients and drugs

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue 4, 1997, Pages 269-276

  Egberts, Antoine C G ^a,b   De Koning, Fred H P ^a,b   Meyboom, Ronald H B ^a   Leufkens, Hubert G M ^b  

^a Netherlands Pharmacovigilance F   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adverse drug reaction; Postmarketing surveillance; Reporting rate; Spontaneous reporting system; Telephone

Indexed keywords

ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CONTRACEPTIVE AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; DIURETIC AGENT; DRUG; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT;

ADVERSE DRUG REACTION; ARTICLE; DRUG SURVEILLANCE PROGRAM; INFORMATION SERVICE; INTERMETHOD COMPARISON; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; TELEPHONE;

EID: 0030854196     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199707)6:4<269::AID-PDS290>3.0.CO;2-Y     Document Type: Article

References (21)

1. Van der Velden, J. W. I do not want two diseases, one nature made, and one doctor made. Pharmacoepidemiology and Drug Safety 1995; 4: 45.
2. Sigell, L. T., Piascik, M. F., Parker, R. E., Nelson, E. D. and Williams, R. B. Consumer focus of a university drug and poison information service. American Journal of Hospital Pharmacy 1980; 37: 1206-1210.
3. Conner, C. S., Murphey, K. J., Sawyer, D., Murakami, K., Rumack, B. H. and Ford, P. S. Drug information services for consumers and health professionals. American Journal of Hospital Pharmacy 1980; 37: 1215-1219.
4. Meyboom, R. H. B. Een medicijnlijn als instrument voor postmarketing surveillance (A telephone medicines information service as a tool for post-marketing surveillance). In: Aanzet tot een medicijnlijn. Visser, T. J. (Ed.), Wetenschapswinkel, Leiden, 1990, pp. 25-27.
5. De Koning, G. H. P. A regionalized spontaneous surveillance program for adverse drug reactions as a tool to improve pharmacotherapy. PhD thesis, University of Utrecht, Utrecht, 1993.
6. Anonymous. Anatomical Therapeutic Chemical (ATC) Classification Index. WHO Collaborating Centre for Drug Statistics Methodology, Oslo, 1994.
7. Anonymous. Foundation for Pharmaceutical Statistics 1994. KNMP, The Hague, 1995.
8. Meade, V. Patient telephone services multiply. American Pharmacy 1991; NS31: 29-31.
9. Kellaway, G. The patient. In: Monitoring for Drug Safety. Inman, W. H. W. (Ed.), MTP Press Limited, Lancaster, 1986, pp. 637-649.
10. Lamb, G. C., Green, S. S. and Heron, J. Can physicians warn patients of potential side effects without fear of causing those side effects? Archives of Internal Medicine 1994; 154: 2753-2756.
11. Connell, C. M. and Crawford, C. O. How people obtain their health information - a survey in two Pennsylvania counties. Public Health Reports 1988; 103: 189-195.
12. Swinkels, H. Health interview surveys. Trendfigures Netherlands Health Interview Survey 1981-1992. Maandbericht Gezondheidsstatistiek CBS 1993: 4-28.
13. Kando, J. C., Yonkers, K. A. and Cole, J. O. Gender as a risk factor for adverse events to medications. Drugs 1995; 50: 1-6.
14. Cookson, J. Side-effects of antidepressants. British Journal of Psychiatry 1993; 163 (Suppl. 20): 20-24.
15. Simon, G. Psychiatric disorders and functional somatic symptoms as predictors of health care use. Psychiatric Medicine 1992; 10: 49-60.
16. Wiholm, B. E., Olsson, S., Moore, N. and Wood, S. Spontaneous reporting systems outside the United States. In: Pharmacoepidemiology. Strom, B. L. (Ed.), Wiley, Chicester, 1994, pp. 139-155.
17. Strom, B. L. Pharmacoepidemiology: response to the challenge. Pharmacoepidemiology and Drug Safety 1995; 4: 11-14.
18. Mitchell, A. S., Henry, D. A., Hennrikus, D. and O'Connell, D. L. Adverse drug reactions: can consumers provide early warning? Pharmacoepidemiology and Drug Safety 1994; 3: 257-264.
19. Mitchell, A. S., Henry, D. A., Sanson-Fisher, R. and O'Connell, D. L. Patients as a direct source of information on adverse drug reactions. British Medical Journal 1988; 297: 891-893.
20. Fisher, S. and Bryant, S. G. Postmarketing surveillance: accuracy of patient drug attribution judgments. Clinical Pharmacology and Therapeutics 1990; 48: 102-107.
21. Altman, D. G. Practical Statistics for Medical Research. Chapman & Hall, London, 1991, pp. 404-408.